STEAP3 and glioblastoma: Importantly, recent in silico analysis of a serum exosome-derived ceRNA network has identified STEAP3-AS1 as an independent prognostic predictor of glioblastoma and gallbladder cancer [48, 49], further proving its clinic value as a promising biomarker for cancers.